Cure My Disease

Don't miss your cure!

 Log in / Sign up

New antibiotic OMN6 tested against tough lung infection

NCT ID NCT06087536

Recruiting now Disease control Sponsor: Omnix Medical Ltd Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This phase 2a trial tests an experimental antibiotic called OMN6 in 54 adults with hospital-acquired or ventilator-associated pneumonia caused by Acinetobacter baumannii. Participants receive either OMN6 or a placebo, plus standard antibiotics, for one day. The main goal is to check safety and how the drug moves through the body.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
OMN6 (an experimental antibiotic given intravenously)
What this could lead to
If successful, this could point toward a new treatment option for a hard-to-treat lung infection in hospitalized patients.
What could go wrong
This is an early phase 2a trial with only 54 participants, focused on safety and dosing—not yet on effectiveness. The drug is given for just one day alongside standard antibiotics, so its added benefit is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nosocomial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Omnix Medical Research Site

    RECRUITING

    Ashdod, Israel

  • Omnix Medical Research Site

    RECRUITING

    Be’er Ya‘aqov, Israel

  • Omnix Medical Research Site

    RECRUITING

    Holon, Israel

  • Omnix Medical Research Site

    RECRUITING

    Petah Tikva, Israel

  • Omnix Medical Research Site

    RECRUITING

    Ramat Gan, Israel

  • Omnix Medical Research Site

    RECRUITING

    Rishon LeZiyyon, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.